Dermatology
Clinical and Laboratory Investigations
Acquired Nevoid TelangiectasiaWollina U.a · Barta U.a · Uhlemann C.b · Oelzner P.cDepartments of aDermatology and Allergology, bPhysical Therapy and Rehabilitative Medicine and cRheumatology and Osteology/Internal Medicine IV, School of Medicine, Friedrich Schiller University of Jena, Germany
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: September 03, 2001
Issue release date: 2001
Number of Print Pages: 3
Number of Figures: 1
Number of Tables: 0
ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)
For additional information: https://www.karger.com/DRM
Abstract
Background: Acquired nevoid telangiectasia (ANT) is a segmental dilatation of papillary plexus vessels. Objective: In the present study, the frequency of ANT and its associations with collagen vascular and spinal disease have been investigated. Methods: 188 unselected patients, seen at an interdisciplinary dermatorheumatologic outpatient clinic, were clinically examined for the presence of ANT and possible associations to preexisting disease. Results: ANT was seen in 17% of patients, all females. The mean age of ANT patients was 57.5 ± 8.2 years. Most common diseases were lupus erythematosus and scleroderma. Twenty-four of them suffered from generalized fibromyalgia, 8 had spondylitis deformans, 1 suffered from thoracal syringomyelia and 1 had a spine trauma. Two types of ANT have been seen: the cervicothoracal transition type and the lumbosacral transition type. Conclusions: ANT is not uncommon among patients attending a dermatorheumatologic outpatient clinic. ANT indicates spinal or neuromuscular complaints, but is not related to collagen vascular disease itself.
© 2001 S. Karger AG, Basel
Related Articles:
References
- Patrizi A, Neri I, Orlandi C, Marini R: Sacral medial telangiectatic vascular nevus: A study of 43 children. Dermatology 1996;192:301–306.
- Schepis C, Greco D, Bosco P, Ragusa A, Romano C: Medial telangiectatic sacral nevi (types A and C) associated with Williams syndrome. Dermatology 2000;201:285–286.
- Requena L, Sangueza OP: Cutaneous vascular abnormalities. I. Hamartomas, malformations, and dilatation of preexisting vessels. J Am Acad Dermatol 1997;37:523–549.
- Hein G, Wollina U, Uhlemann C: Management of dermato-rheumatic syndromes. Br J Rheumatol 1998;37:463.
-
Wollina U, Barta U, Tanner E, Uhlemann C, Hein G, Knopf B: Interdisziplinäre Betreuung von Patienten mit Kollagenosen – das Jenaer Modell. Z Hautkrankh 1993;68:602–606.
-
Gräfe A, Wollina U, Tebbe B, Sprott H, Uhlemann C, Hein G: Fibromyalgia in lupus erythematosus. Acta Derm-Venereol (Stockh) 1999;79:62–64.
- Smoller BR, Rosen S: Port wine stains: A disease of altered neural modulation of blood vessels? Arch Dermatol 1986;122:177–179.
- Adams BB, Lucky AW: Acquired port-wine stains and antecedent trauma: Case report and review of the literature. Arch Dermatol 2000;136:897–899.
- Kainz JT, Soyer H-P, Strasser-Fuchs S, Smolle J: Erworbener Naevus flammeus (Fegeler-Syndrom). Hautarzt 1991;42:289–292.
Article / Publication Details
Published online: September 03, 2001
Issue release date: 2001
Number of Print Pages: 3
Number of Figures: 1
Number of Tables: 0
ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)
For additional information: https://www.karger.com/DRM
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
